Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Sujet Principal
Gamme d'année
1.
Rev. Soc. Bras. Clín. Méd ; 16(4): 235-237, out.-dez. 2018. ilus.
Article Dans Portugais | LILACS | ID: biblio-1025924

Résumé

A síndrome POEMS é um distúrbio multissistêmico. Sua patogênese não está totalmente estabelecida, mas sabe-se que tem relação com fator de crescimento vascular endotelial, interleucinas e fator de necrose tumoral alfa. A idade média de incidência é 50 anos, com maior prevalência em homens. Neuropatia periférica e gamopatia monoclonal estão presentes em todos os pacientes e são consideradas critérios maiores; quando associadas a pelo menos um critério menor, estabelecem diagnóstico da síndrome. As opções de tratamento são radioterapia, corticosteroides e quimioterapia, além de transplante autólogo de células-tronco hematopoiéticas. (AU)


POEMS syndrome is a multisystem disorder. Its pathogenesis isn't fully established, but it is known to be related to endothelial vascular growth factor, interleukins, and tumoral necrosis factor alpha (TNF-α). The mean age at incidence is 50 years, with a higher prevalence in men. Peripheral neuropathy and monoclonal gammopathy are present in all patients, and are considered major criteria; when associated with at least one minor criterium, they establish the diagnosis of the syndrome. Treatment options are radiotherapy, corticosteroids, chemotherapy, as well as autologous hematopoietic stem cell transplantation. (AU)


Sujets)
Humains , Mâle , Adulte d'âge moyen , Syndrome POEMS/diagnostic , Ostéosclérose/étiologie , Paraprotéinémies/étiologie , Polyneuropathies/diagnostic , Splénomégalie/imagerie diagnostique , Maladies de la thyroïde/imagerie diagnostique , Dexaméthasone/usage thérapeutique , Hyperplasie lymphoïde angiofolliculaire , Syndrome POEMS/complications , Syndrome POEMS/traitement médicamenteux , Hormones corticosurrénaliennes/usage thérapeutique , Vascularite leucocytoclasique cutanée/diagnostic , Polyradiculonévrite inflammatoire démyélinisante chronique , Inhibiteurs de l'angiogenèse/usage thérapeutique , Cyclophosphamide/usage thérapeutique , Diagnostic différentiel , Électromyographie , Immunosuppresseurs/usage thérapeutique , Antibiotiques antinéoplasiques/usage thérapeutique , Myélome multiple , Antinéoplasiques/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche